STAGE IV BREAST CANCER
Clinical trials for STAGE IV BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE IV BREAST CANCER trials appear
Sign up with your email to follow new studies for STAGE IV BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New DNA vaccine targets tough breast cancer cells
⭐️ VACCINE ⭐️ OngoingThis early-phase trial tests a DNA vaccine called STEMVAC in 42 people with advanced HER2-negative breast cancer. The vaccine aims to train the immune system to attack cancer stem cells, which are resistant to standard treatments. The study focuses on safety and whether the vacci…
Matched conditions: STAGE IV BREAST CANCER
Phase: PHASE1 • Sponsor: University of Washington • Aim: ⭐️ VACCINE ⭐️
Last updated May 12, 2026 13:42 UTC
-
New hope for hard-to-treat breast cancer: immune-boosting drug combos tested
Disease control OngoingThis study tests whether combining an immunotherapy drug (avelumab) with other medications can help shrink or control advanced triple-negative breast cancer that has spread or cannot be removed by surgery. About 145 adults with stage IV or recurrent triple-negative breast cancer …
Matched conditions: STAGE IV BREAST CANCER
Phase: PHASE2 • Sponsor: Laura Huppert, MD, BA • Aim: Disease control
Last updated May 17, 2026 02:19 UTC
-
Promising drug could delay tumor growth in Hard-to-Treat breast cancer
Disease control OngoingThis study tests a drug called sacituzumab govitecan in people with a common type of advanced breast cancer (HR+/HER2-) that has stopped responding to hormone therapy. The goal is to see if it can keep the cancer from growing longer than current standard chemotherapies. About 654…
Matched conditions: STAGE IV BREAST CANCER
Phase: PHASE3 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New PET scan may predict breast cancer drug success
Diagnosis OngoingThis small pilot study tested whether a special PET scan using a radioactive tracer can predict how well patients with advanced HER2-positive breast cancer respond to the drug ado-trastuzumab emtansine (T-DM1). Ten women with cancer that had spread to other parts of the body rece…
Matched conditions: STAGE IV BREAST CANCER
Phase: NA • Sponsor: City of Hope Medical Center • Aim: Diagnosis
Last updated May 15, 2026 11:55 UTC
-
New scan could sharpen detection of aggressive breast cancer
Diagnosis OngoingThis study tests a special PET scan that uses a radioactive tracer to find HER2-positive breast cancer tumors in women with advanced (stage IV) disease. The goal is to see if this scan can better identify which tumors have the HER2 protein, helping doctors plan more targeted trea…
Matched conditions: STAGE IV BREAST CANCER
Phase: NA • Sponsor: City of Hope Medical Center • Aim: Diagnosis
Last updated May 13, 2026 15:59 UTC